Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (VTYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 340,707
  • Shares Outstanding, K 59,048
  • Annual Sales, $ 0 K
  • Annual Income, $ -108,430 K
  • 60-Month Beta -1.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.62
Trade VTYX with:

Options Overview Details

View History
  • Implied Volatility 189.28% ( -11.44%)
  • Historical Volatility 176.51%
  • IV Percentile 92%
  • IV Rank 32.73%
  • IV High 457.20% on 02/07/24
  • IV Low 58.94% on 09/19/23
  • Put/Call Vol Ratio 0.25
  • Today's Volume 4,533
  • Volume Avg (30-Day) 1,312
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 10,902
  • Open Int (30-Day) 5,613

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.78
  • Number of Estimates 7
  • High Estimate -0.54
  • Low Estimate -1.02
  • Prior Year -0.62
  • Growth Rate Est. (year over year) -25.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.95 +243.91%
on 01/25/24
7.50 -10.53%
on 02/21/24
+4.69 (+232.18%)
since 01/23/24
3-Month
1.87 +259.79%
on 01/19/24
7.50 -10.53%
on 02/21/24
+4.34 (+183.12%)
since 11/22/23
52-Week
1.87 +259.79%
on 01/19/24
47.25 -85.80%
on 03/03/23
-36.76 (-84.56%)
since 02/23/23

Most Recent Stories

More News
Why Shares of Ventyx Biosciences Are Dropping Tuesday

Investors were unimpressed by the company's trial results for an ulcerative colitis therapy.

PFE : 27.76 (+0.76%)
VTYX : 6.71 (+16.29%)
Why Shares of Ventyx Biosciences Rose Monday

The company has several promising autoimmune therapies.

DICE : 47.55 (+0.06%)
RXDX : 199.92 (+0.09%)
MRK : 129.45 (+0.15%)
LLY : 769.54 (-0.01%)
VTYX : 6.71 (+16.29%)
Take the Zacks Approach to Beat the Market: Uber, Baidu, AssetMark in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

ITW : 260.13 (+0.56%)
HSY : 193.83 (+0.15%)
BIDU : 111.36 (+0.70%)
CLX : 152.84 (+0.16%)
INTU : 659.81 (+0.29%)
AXON : 270.63 (-0.34%)
NOBL : 96.86 (+0.47%)
UBER : 78.20 (+0.22%)
AMK : 33.65 (+1.17%)
TERN : 8.13 (+2.78%)
VTYX : 6.71 (+16.29%)
Recent Price Trend in Ventyx Biosciences, Inc. (VTYX) is Your Friend, Here's Why

Ventyx Biosciences, Inc. (VTYX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made...

VTYX : 6.71 (+16.29%)
Wall Street Analysts See a 26.67% Upside in Ventyx Biosciences, Inc. (VTYX): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Ventyx Biosciences, Inc. (VTYX). While the effectiveness of this highly sought-after metric is questionable,...

VTYX : 6.71 (+16.29%)
Ventyx Biosciences, Inc. (VTYX) Is a Great Choice for 'Trend' Investors, Here's Why

Ventyx Biosciences, Inc. (VTYX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

VTYX : 6.71 (+16.29%)
Are You Looking for a Top Momentum Pick? Why Ventyx Biosciences, Inc. (VTYX) is a Great Choice

Does Ventyx Biosciences, Inc. (VTYX) have what it takes to be a top stock pick for momentum investors? Let's find out.

VTYX : 6.71 (+16.29%)
Wall Street Analysts Think Ventyx Biosciences, Inc. (VTYX) Could Surge 38.99%: Read This Before Placing a Bet

The consensus price target hints at a 39% upside potential for Ventyx Biosciences, Inc. (VTYX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

VTYX : 6.71 (+16.29%)
Here's Why Momentum in Ventyx Biosciences, Inc. (VTYX) Should Keep going

Ventyx Biosciences, Inc. (VTYX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made...

VTYX : 6.71 (+16.29%)
Wall Street Analysts Predict a 71% Upside in Ventyx Biosciences, Inc. (VTYX): Here's What You Should Know

The mean of analysts' price targets for Ventyx Biosciences, Inc. (VTYX) points to a 70.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

VTYX : 6.71 (+16.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ventyx Biosciences Inc. is a clinical-stage biopharmaceutical company. It focused on advancing new therapies for patients living with inflammatory diseases and autoimmune disorders. The company's clinical stage pipeline includes VTX958, VTX002 and VTX2735. Ventyx Biosciences Inc. is headquartered in...

See More

Key Turning Points

3rd Resistance Point 9.14
2nd Resistance Point 8.20
1st Resistance Point 7.45
Last Price 6.71
1st Support Level 5.76
2nd Support Level 4.82
3rd Support Level 4.07

See More

52-Week High 47.25
Fibonacci 61.8% 29.91
Fibonacci 50% 24.56
Fibonacci 38.2% 19.20
Last Price 6.71
52-Week Low 1.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar